Optimal Sequential Predictive Probability Designs for Early-Phase Oncology Expansion Cohorts.

The optimal efficiency design allows investigators to preserve limited financial resources and to maintain ethical standards by halting potentially large dose-expansion cohorts early in the absence of promising efficacy results, while maintaining traditional control of type I and II error rates.